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Abstract
Recent genome-wide association (GWA) studies have related several genetic loci, including CRP,
HNF1A and LEPR, to circulating C-reactive protein (CRP) levels in populations of European
ancestry. The genetic effects in other populations and across varying levels of exposure to a
pathogenic environment, an important environmental factor associated with CRP, remain to be
determined. We tested 2,073,674 SNPs for association with plasma CRP (limited to ≤ 10 mg/L) in
1,709 unrelated Filipino women from the Cebu Longitudinal Health and Nutrition Survey
(CLHNS). The strongest evidence of association was observed with variants at CRP (rs876537, P
= 1.4 × 10−9) and HNF1A (rs7305618, P = 1.0 × 10−8). Among other previously reported CRP
associated loci, the APOE ε4 haplotype was associated with decreased CRP level (P = 7.1 × 10−4),
and modest association was observed with LEPR (rs1892534, P = 0.076), with direction of effects
consistent with previous studies. The strongest signal at a locus not previously reported mapped to
a gene desert region on chromosome 6q16.1 (rs1408282, P = 2.9 × 10−6). Finally, we observed
nominal evidence of interaction with exposure to a pathogenic environment for top main effect
SNPs at HNF1A (rs7305618, P = 0.031), LEPR (rs1892535, P = 0.030) and 6q16.1 (rs1408282, P
= 0.046). Our findings demonstrate convincing evidence that genetic variants in CRP and HNF1A
contribute to plasma CRP in Filipino women, and provide the first evidence that exposure to a
pathogenic environment may modify the genetic influence at the HNF1A, LEPR and 6q16.1 loci
on plasma CRP level.
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C-reactive protein (CRP), initially recognized as a hallmark of inflammation and the acute-
phase response, is a powerful marker for risk of cardiovascular disease (CVD), type 2
diabetes and metabolic syndrome [1]. Family studies have estimated that inter-individual
variation in blood CRP is 35–40% heritable [2]. Recent GWA studies have identified several
genetic loci significantly associated (P < 5×10−8) with plasma CRP. Seven loci identified in
the Women’s Genome Health Study (WGHS), including signals at CRP, HNF1A, IL6R,
APOE, LEPR, GCKR and 12q23.2 accounted for 10.1% of the variation in CRP levels in
Caucasian women [3]. Further confirmatory evidence was provided by the
Pharmacogenomics and Risk of Cardiovascular Disease (PARC) study that variants at CRP,
HNF1A and APOE were associated with plasma CRP in Europeans [4]. However, it remains
to be determined what loci are most strongly associated with CRP levels in populations of
non-European ancestry.
The genetic variants identified by prior GWA studies explain only a small fraction of the
total variation believed to reflect genetic effects on CRP level. Both gene-gene and gene-
environment interactions may underlie complex phenotypes [5] [6]. According to a 2004
World Health Organization report, infectious diseases still account for more than 30% of all
mortality in Southeast Asia [7]. In the Philippines, respiratory infection ranked among the
top causes of mortality in 2006 [8]. As a major source of inflammatory stimuli, exposure to
a pathogenic environment results in elevated levels of CRP. Earlier investigations in
CLHNS samples showed convincing evidence of the role of exposure to a pathogenic
environment in predicting plasma CRP levels in Filipinos [9–10]. The burden of
environmental inflammatory stimuli in CLHNS samples provides an opportunity to explore
whether exposure to a pathogenic environment interacts with genetic variants to influence
CRP concentrations.
In light of the important roles of both genetic variation and exposure to a pathogenic
environment in predicting circulating CRP levels, the primary purposes of this study were to
conduct a GWA scan to identify loci associated with plasma CRP levels in Filipino women
and to examine whether the genetic contributions to CRP levels interact with exposure to a
pathogenic environment in this population.
Methods
Study population and data collection
The study sample consisted of 1,798 healthy Filipino women from the CLHNS, an on-going
community-based study of mother-child pairs that began in 1983. The study population,
design and protocols for this longitudinal cohort have been previously described [11]. Data
for this paper come from the 2005 CLHNS survey on the mothers. Written informed consent
was obtained from all participants, and study protocols were approved by the University of
North Carolina Institute Review Board for the Protection of Human Subjects.
Anthropometric measurements and comprehensive data on household demographics, income
levels, environmental quality and health behaviors were collected through in-home
interviews administered by trained staff (data available online at
http://www.cpc.unc.edu/projects/cebu). Overnight fasting blood samples were obtained at
the 2005 survey and collected into EDTA-coated tubes. Plasma CRP concentrations were
measured by a high-sensitivity immunoturbidimetric method (Synchron LX20, lower
detection limit: 0.1 mg/L; Beckman Coulter, Fullerton, CA) with between-assay coefficient
of variations (CVs) < 7.6 across the assay range [9]. Seventy-seven participants with CRP
levels > 10 mg/L were excluded from the initial analysis. The general characteristics of
1,709 samples with CRP levels ≤10 mg/L are presented in Supplementary Table 1.
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Based on collection of multiple proxy measures of the likelihood of exposure to infectious
microbes, a pathogen score was constructed using the mean value of five interviewer-
assigned variables, each scored on a 3-point scale (0 = low exposure, 1 = moderate and 2 =
high): (1) cleanliness of the food preparation area; (2) means of garbage disposal; (3)
presence of excrement near the house; (4) level of garbage; and (5) excrement present in the
neighborhood surrounding the household [9]. The pathogen score was negatively correlated
with socio-economic status as measured by household income (corr: −0.198, P < 0.0001)
and household assets (corr: −0.333, P < 0.0001) and with waist circumference (corr: −0.106,
P < 0.0001) (Supplementary Table 2). In addition, a dichotomous variable (0, 1) was
constructed based on whether participants reported any symptoms of infection at the time of
blood collection. Symptoms included runny nose, cough, fever, diarrhea, sore throat and the
more general categories of flu, cold and sinusitis.
GWA SNP genotyping and imputation
SNP genotyping was conducted using the Affymetrix Genome-wide Human SNP Array 5.0
and quality control was performed, both as previously described [12]. Briefly, samples with
<97% genotyping call rate were excluded, as were 81 members of estimated first-degree
relative pairs. SNPs were excluded for call rate < 90%, deviation from Hardy-Weinberg
equilibrium (P <10−6), ≥ 3 discrepancies among duplicate pairs, Mendelian inheritance
errors among five CEPH trios and/or CEPH sample genotype discrepancies with HapMap.
Genotype imputation was conducted using MACH [13] and 352,264 genotyped SNPs that
were polymorphic in both HapMap phase II CEU and CHB+JPT samples. After excluding
SNPs with r2 ≤ 0.3 or estimated minor allele frequency (MAF) ≤ 0.01, we obtained a final
imputed data set of 1,697,660 SNPs. Missing genotype data for the 352,264 directly
genotyped SNPs were also imputed. In addition, 23,750 directly genotyped SNPs non-
polymorphic in both HapMap populations but with MAF > 0.01 in the CLHNS samples
were also analyzed, for a total of 2,073,674 SNPs tested for association with plasma CRP
level.
Additional imputation within flanking regions of previously reported loci was performed
based on haplotypes created from the 1000 Genomes Project pilot release (June, 2010) of
CEU+CHB+JPT samples. Regional plots were created using LocusZoom [14].
Supplementary genotyping
Due to the unavailability in our genotyped and imputed data, candidate SNPs in the APOE
gene (rs429358 and rs7412) were genotyped by TaqMan allelic discrimination (Applied
Biosystems, Foster City, CA). Two additional assays representing CRP triallelic SNP
rs3091244 were designed as described [15]. The triallelic genotypes were assigned as shown
in Supplementary Table 3, and samples with ambiguous genotypes were genotyped by
Sanger sequencing. For each assay, the genotyping success rate was >98.9% and no
discrepancies among 80 duplicate pairs were observed.
Statistical analysis
CRP values were natural log-transformed after adding the constant 0.10 to satisfy model
assumptions of normally distributed residuals, conditional on the covariates of age in the
year 2005, household assets, natural log-transformed household income, number of previous
pregnancies (as three categories: 0–4, 5–10, ≥ 11), infectious status, pathogenic score, and 7
principal components of genetic variation (Supplementary Table 4). Additional traits were
tested for association at SNPs demonstrating association evidence for CRP. These traits
included waist circumference, BMI, triglycerides, HDL cholesterol, LDL cholesterol, total
cholesterol and homocysteine, among which traits were natural log-transformed except waist
circumference. Array Studio software version 3.2 (OmicSoft, Morrisville, NC) was used to
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perform the initial GWA analyses, and SAS version 9.2 (SAS Institute, Cary, NC) was used
to perform additional analyses for association between selected SNPs and CVD related
traits. A multivariable linear regression model assuming an additive genetic model was used
for association tests. The triallelic SNP rs3091244 was tested for association as a biallelic
SNP considering either the SNP ‘A’ allele or the ‘T’ allele to be the effect allele, in which
CC genotype was coded 0, AC or CT were coded 1, and AA, AT or TT coded 2 under an
additive genetic model. The effects of association with each additional copy of the SNP ‘A’
allele (CC, CT or TT = 0, AC or AT = 1 and AA = 2) or the ‘T’ allele (AA, AC or CC = 0,
AT or CT = 1 and TT = 2) were also evaluated in two separate analyses. In conditional
analysis, we tested the additive genotype effects for each of the SNPs within the flanking
region at each locus in individual linear regression models with the same covariates as above
plus the genotype of the index SNP.
Haplotype analyses were performed using the “haplo.stat” R package. Haplotypes and
haplotype frequencies were estimated using the R function “haplo.em”. The association
between haplotypes and CRP was assessed using the R function “haplo.glm”. An additive
model was assumed, in which the regression coefficient β represents the expected change in
CRP level with each additional copy of the specific haplotype compared to the reference
haplotype. The most common T-C (APOE ε3) haplotype of rs429358 and rs7412 was set as
the reference haplotype. The R function “haplo.score” was used to compute the global score
statistics to test the overall association between haplotypes and CRP. The same covariates
used for genotype analysis were also applied in the haplotype analysis models.
The seven SNPs displaying the strongest evidence for association at each of the seven loci
were included in interaction analyses between genotype and exposure to a pathogenic
environment. The intensity of exposure to a pathogenic environment was dichotomized into
a lower exposure group (pathogen score < 0.5, n = 877) and a higher exposure group
(pathogen score ≥ 0.5, n = 832), using the median pathogen score as the cut-off point. P
values for genotype by pathogenic score interaction < 0.05 were considered to be significant.
Results
Tests of association between 2,073,674 SNPs and plasma CRP in 1,709 unrelated CLHNS
mothers resulted in 28 SNPs at three loci that showed evidence of association at a threshold
of P < 5 × 10−6 (Figure 1). The observed genomic control inflation factor (λGC) was 1.02,
suggesting no substantial population stratification. Consistent with the findings of previous
GWA study in populations of European ancestry, the most compelling associations were
observed at CRP (best P = 1.4 × 10−9 for rs876537) and HNF1A (best P = 1.0 × 10−8 for
rs7305618) (Table 1, Figure 1). Conditional analysis for SNPs within the CRP locus
suggested that the CRP SNPs likely represented a single signal for plasma CRP in CLHNS
mothers (all conditioned P > 0.03, Supplementary Table 5A). Conditioning on the HNF1A
variant rs7305618, we observed no evidence for a secondary signal at the HNF1A locus (all
conditioned P > 0.08, Supplementary Table 5B). Additionally, a suggestive signal at a locus
not previously reported to be associated with CRP mapped to a gene desert region on
chromosome 6q16.1 (rs1408282, best P = 1.4 × 10−6, Table 1). Conditional analysis
revealed that there were no other SNPs located in the region with independent evidence for
association with plasma CRP (all conditioned P > 0.36, Supplementary Table 5C).
We next tested whether adjustment for waist circumference, a known predictor of CRP level
[9–10], would affect the observed genetic associations. The waist-adjusted association
became stronger for the CRP (rs876537, P = 3.4 × 10−11) and HNF1A (rs7305618, P = 4.0 ×
10−10) loci (Table 1), suggesting that accounting for waist circumference removed an
independent source of variation in CRP levels. Results were consistent in an analysis that
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also included the 77 additional study participants that were excluded in the initial analysis
due to CRP levels > 10 mg/L (data not shown).
We next examined whether additional CRP-associated loci identified in European
populations were replicated in the CLHNS, using a definition of replication as P < 0.05 and
consistent direction of effect. Among the SNPs that were both previously identified [3] and
available in CLHNS samples, the widely reported CRP gene variant rs1205 (P = 8.5 × 10−9)
provided convincing evidence for association with CRP level (Table 2). The triallelic CRP
variant rs3091244 shown previously to affect CRP promoter activity and influence the gene
transcription [16] displayed significant association in the same direction in CLHNS samples
(β = 0.257, P = 5.2 × 10−7, tested as a biallelic SNP considering the allele A or T to be the
effect allele). Specifically, the SNP ‘A’ allele and ‘T’ allele displayed consistent direction of
association, and were significantly associated with increased CRP levels when we examined
the effect of the A and T allele separately in two analyses (A allele: β = 0.245, P = 3.8 ×
10−5; T allele: β = 0.183, P = 0.023). The frequency of the rs3091244 alleles differ between
CLHNS (C:0.79, A:0.13, T: 0.08) and predominantly European-descended participants in
the Framingham Heart Study (C:0.62, A:0.07, T: 0.31) [17]. Reciprocal conditional analysis
suggested that despite not representing an independent effect, the SNP rs876537 was likely
to be a stronger signal compared to rs3091244 at the CRP locus (P for rs876537 conditional
on rs3091244 = 6.8 × 10−4; P for rs3091244 conditional on rs876537 = 0.12). We also
provided evidence for the association with the two previously studied nonsynonymous SNPs
in the HNF1A gene (P = 1.4× 10−7 for Ile27Leu and 7.5 × 10−6 for Ser486Asn).
Additionally, significant association was observed for the intronic SNPs rs1169286 (P = 5.1
× 10−7) and rs7310409 (P = 1.6 × 10−6) within the first intron of HNF1A, consistent with
previous studies for these SNPs [4]. For the LEPR, IL6R, GCKR and chromosome 12q23.2
loci, our study had > 89% power, using a significance threshold of α = 0.05 to detect the
reported percentage of total variation explained by each additional copy of the effect allele
[3]. The signal at LEPR did not meet our replication threshold; however, it showed modest
evidence of association (rs1892534, P = 0.076) with a consistent direction of effect as
reported previously. We did not replicate associations with other reported GWA study SNPs
at IL6R (rs4129267, P = 0.24), GCKR (rs1260326, P = 0.20), and chromosomal region
12q23.2 (rs10778213, P = 0.63), although the directions of effect were consistent with the
previous report for IL6R and GCKR SNPs.
As the APOE SNPs rs769449 and rs2075650 reported by the WGHS[3] were not genotyped
or well-imputed in CLHNS samples, we investigated for association between CRP level and
the APOE variants rs429358 and rs7412 that comprise the APOE ε2, ε3, and ε4 haplotypes
[18] (Table 3). The APOE SNP rs429358 was significantly associated with CRP levels (P =
4.8 × 10−4) under an additive model. Given the small number of 15 minor C allele
homozygotes, we also performed a test assuming a dominant model and observed that the
CRP levels were significantly lower in C allele carriers (P = 1.0 × 10−4). Haplotype analysis
based on a score statistic provided compelling evidence for an overall association between
APOE haplotypes and CRP level (Global P = 2.6 × 10−3). The APOE ε4 haplotype with a
frequency of 0.085 was significantly associated with lower CRP (P = 7.1 × 10−4), whereas
the most common haplotype APOE ε3 with an estimated frequency of 0.779 was modestly
associated with elevated CRP (P = 0.01) (Table 3). Further analysis that evaluated the effect
on CRP level of each additional copy of the specific haplotype compared with the
homozygote reference haplotype (APOE ε3) suggested that the APOE ε4 haplotype was
significantly associated with decreased level of CRP (β = −0.269, P = 5.9 × 10−4).
Additional variation within flanking regions of the CRP associated loci was investigated by
assessing the association of SNPs imputed based on 1000 Genomes Project Pilot data. We
observed a non-HapMap SNP rs2592902 (P = 7.3 × 10−10) showing slightly stronger
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association compared to rs876537 (P = 2.0 × 10−9), the lead SNP at the CRP locus
(Supplementary Figure 1). Reciprocal conditional analysis provided no evidence for
independent effects (conditional P for rs876537 = 0.59, conditional P for rs2592902 = 0.13).
Further, conditioning on rs876537, none of the remaining 220 SNPs in this 200 kb gene
region (chr1: 157,841,557–158,041,557) showed evidence for a secondary signal at the CRP
locus (conditional P > 0.005). Additionally, the comprehensive imputation of 283 SNPs in a
200 kb flanking region (chr12: 119,787,315–119,987,315) of HNF1A index SNP rs7305618
(P = 5.2 × 10−8) revealed stronger evidence of association for CRP level with the HNF1A
promoter SNP rs2255531 (P = 2.9 × 10−8). The findings based on the reciprocal conditional
analysis provided little evidence for their independence (conditional P for rs7305618 = 0.35,
conditional P for rs2255531 = 0.15). In models accounting for rs7305618, the strength of the
association with the remaining SNPs were greatly attenuated (conditional P > 0.024),
suggesting no separate signal at the HNF1A locus for plasma CRP. Further analysis using
the 1000 Genome Project imputed SNPs within 2 Mb expansive flanking regions of the
previously reported loci including LEPR, IR6R, APOE, GCKR and 12q23.2 did not produce
compelling evidence for additional CRP associated signals in CLHNS samples (data not
shown).
We next tested whether the intensity of exposure to a pathogenic environment modifies the
effects of genotypes on plasma CRP in Filipino women. Among eight SNPs at seven
previously reported loci and at the suggestive signal at 6q16.1, nominally significant
interactions were detected between genotype and pathogen score on plasma CRP for the
SNPs HNF1A rs7305618 (P = 0.031), LEPR rs1892534 (P = 0.030) and 6q16.1 rs1408282
(P = 0.046) (Table 4). In a secondary analysis stratifying by pathogen score (see Methods)
above (n=832) or below (n=877) the median value, the estimated increase in log-CRP level
for each additional T allele for the HNF1A SNP rs7305618 was 0.348 (P = 1.3× 10−7) in
individuals with higher pathogen score but was only 0.181 (P = 0.0063) in those with lower
pathogen score. Similar findings were detected for the SNP rs1408282 at 6q16.1 with strong
and significant association predominantly detected in individuals with higher pathogen score
(β = 0.593, P = 1.5× 10−6) compared to those with lower pathogen score (β = 0.226, P =
0.057). We observed that the genetic influence of LEPR variant rs1892534 on plasma CRP
is stronger in individuals under lower exposure to a pathogenic environment (β = 0.249, P =
0.0047) than those having higher exposure (β = 0.068, P = 0.44). Additionally, we found no
evidence for genotype by waist circumference interaction on plasma CRP in Filipino women
(All P for interaction > 0.20).
As plasma CRP is highly correlated with several traits related to CVD, we further explored
whether the CRP-associated SNPs were also significantly associated with quantitative traits
including BMI, waist circumference, lipid profile, and homocysteine. Strong associations
were observed for the APOE variant rs729358 with LDL-C (P = 6.5× 10−7) and with total
cholesterol levels (P = 7.2× 10−5) (Table 5). Significant evidence for association was also
found for GCKR variant rs1260326 with triglyceride level (P = 0.0064), for CRP variant
rs3091244 with triglycerides (P = 0.036) and with LDL cholesterol (P = 0.048). In an
exploratory analysis to assess whether the associations between CRP associated SNPs and
CVD related traits were mediated by CRP concentrations, adjustment for plasma CRP did
not attenuate results (Supplementary Table 6).
Discussion
In this GWA study of plasma CRP in Filipino women, we observed evidence of association
(P < 5 × 10−8) with SNPs at CRP and HNF1A, provided supporting evidence for SNPs at
APOE and LEPR, and detected suggestive evidence at a novel locus on chromosome 6. The
five loci together explain an estimated proportion of CRP variance of 5.6% in CLHNS
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women. We further observed that the associations between CRP concentrations and HNF1A
genetic variants were stronger in women with a higher level of exposure to a pathogenic
environment.
Our strongest association result mapped to the CRP locus on chromosome 1, and explained
~2.0% of the total variation in plasma CRP in CLHNS samples. Encoding the protein CRP,
the gene CRP has been widely investigated as a candidate gene for circulating CRP level.
Several CRP variants including the promoter triallelic SNP rs3091244 [16–17], synonymous
SNP rs1800947 [19–20], 3′ UTR variant rs1130864 [20–21] and 3′ flanking variant rs1205
[22–23] have been reproducibly reported to associate with circulating CRP. The
Framingham Heart Study (FHS), based on 3,301 predominantly European-descended
participants, revealed that rs3091244 was the only SNP that remained significantly
associated with CRP level after accounting for correlation with other SNPs. An in vitro
study further suggested its functional importance by demonstrating that the transcription
factor binding occurred only when the variant T allele was present [16]. In our study, we
observed strong evidence of the association with the triallelic SNP rs3091244 (P = 5.2 ×
10−7). However, the T allele suggested to be functionally relevant, only displayed modest
association with increased CRP level in CLHNS samples (P = 0.021), and the lower
frequency of the T allele in Filipinos (T: 0.08) compared to that in Framingham (T: 0.31)
suggested a difference in genetic background on the CRP gene promoter region between
populations. As the lead SNP showing the strongest association with plasma CRP in our
GWA study, the variant rs876537 residing 7 kb downstream of the CRP gene represents a
stronger signal for CRP than the triallelic SNP rs3091244 based on our findings of
reciprocal conditional analysis (conditioned P for rs3091244 = 0.12, P for rs876437 = 6.8 ×
10−4, Supplementary Table 5A). Additional investigation of the association of SNPs
imputed based on 1000 Genome Project Pilot data within the 200 kb flanking region of the
SNP rs876537, together with the analysis results from conditioning on rs876537 revealed no
separate signal for CRP level at the CRP locus in CLHNS (Supplementary Figure 1). Of
note, the strongest CRP associated SNPs imputed from either HapMap or 1000 Genomes
Project Pilot data were both mainly clustered in the 3′-UTR or 3′ flanking region of CRP
gene (chr1: 157,919,000 –157,949,000). As these gene regions are involved in post-
transcriptional processes by regulating mRNA stability, mRNA localization and
translational efficiency, SNPs in this region may affect protein production as well as
circulating CRP levels. Thus, fine-mapping in this region may help to locate the functional
variants that contribute to the variation in CRP levels.
We confirmed in CLHNS the findings from studies of European origin individuals [3–4]
showing significant association between CRP level and variants at the HNF1A locus. The
proportion of CRP variation explained by HNF1A was 1.9% in our study, higher than the
previously reported 1.1% in Europeans [3]. The protein HNF1α is shown to bind directly to
the CRP promoter to activate gene transcription and to promote cytokine-driven CRP gene
expression [24]. Given the complex role of HNF1α in modulating the expression of target
genes like CRP, common variants at HNF1A locus are suggested to alter the gene and
protein function via multiple mechanisms [25]. The missense variants rs1169288 (Ile27Leu)
and rs2464196 (Ser486Asn) were previously reported to show association with CRP level
and suggested to be functionally relevant [25]. We observed significant association with
these two variants in CLHNS women (P = 1.4 × 10−7 and 7.5 × 10−6 for Ile27Leu and
Ser482Asn, respectively), but conditional analysis suggested that the lead SNP in this region
(rs7305618) represents a stronger signal at the HNF1A locus, thus providing little evidence
for Ile27Leu (conditional P = 0.0033 for rs7305618 and 0.089 for Ile27Leu) or Ser482Asn
(conditional P = 0.0002 for rs7305618 and 0.78 for Ile27Leu) to be functional. Using data
imputed based on 1000 Genome Project, we observed that the strongest signals in the
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CLHNS samples for CRP at the HNF1A locus were located near the promoter and 5′
flanking region of the gene (Data not shown).
We did not observe evidence for association between CRP level and the IL6R, GCKR, and
12q23.2 loci reported in WGHS, although the estimated directions of effect were the same
for IL6R and GCKR. Further analysis using the 1000 Genome Project imputed SNPs within
2 Mb flanking gene regions of these reported loci did not provide evidence for additional
CRP associated signals. As we had > 89% power to detect the reported percentage of total
variation explained by each additional copy of the effect allele [3] in CLHNS, the
inconsistent findings between studies may be attributed to an overestimation of the original
associations owing to the “winner’s curse” [26], or differing genetic or environmental
backgrounds between populations.
This current study provided evidence for interaction between a gene and exposure to a
pathogenic environment on CRP level in CLHNS women. Pathogen exposure was
determined by interviewer assessment of several measures that serve as proxies for exposure
to infectious microbes (see Methods). As suggested, taking account of gene by environment
interactions may help elucidate the potential environmental factors that affect only a
subgroup of genetically susceptible individuals and provide insight into the biological
mechanisms underlying complex diseases [27]. Pathogen exposure is a strong determinant
for elevated CRP concentration, as CRP has the capacity to recognize pathogens and
participates in the systemic response to acute inflammatory stimulus by recruiting and
activating complement, opsonizing pathogens, and promoting activity of phagocytic cells
[28]. Prior findings of a strong correlation between exposure to a pathogenic environment
and CRP in the CLHNS sample provided impetus to further examine gene-by-pathogen
interactions on CRP level [9–10]. Our findings suggest that the genetic effects of HNF1A
(rs7305618), LEPR (rs1892534) and 6q16.1 (rs1408282) on plasma CRP differ with
exposure to a pathogenic environment and that the exposure may modify the genetic
susceptibility to elevated CRP level in Filipino women.
Prior CLHNS studies noted that CRP levels were substantially lower in the Philippines than
in the United States [9–10]. The shared genetic variants associated with CRP concentrations
identified in prior GWA scans, and in the Filipinos studied here [3–4] suggest that the
variation in CRP level across ethnicities is not explained by differences in genetic
background across populations, but largely by environmental and developmental factors.
Interestingly, the recent finding that higher level of microbial exposures in infancy predicted
lower CRP levels in adulthood among the offspring of the mothers studied here suggests that
developmental plasticity is an important influence on the development of anti-pathogen
defenses and could help explain the low CRP levels in the Philippines relative to the US and
elsewhere [29].
In conclusion, we performed a genome-wide association for plasma CRP in a population of
Filipino women. We provide confirmatory evidence for the association of previously
identified loci at CRP and HNF1A, which suggests shared genetic influences on CRP level
between this sample in the Philippines and the European-descended populations studied in
past GWA scans. To our knowledge, this study is the first to report an interaction between
exposure to a pathogenic environment and genetic variants on plasma CRP. These data
suggest that different exposure intensity to a pathogenic environment may modify the effect
of the alleles associated with plasma CRP level. On the basis of the interactive pattern
observed here, further studies in larger populations and investigation into potential
biological mechanisms is warranted.
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Genome-wide association with plasma CRP in CLHNS
(A) Manhattan plot of results from the CLHNS genome-wide association study of plasma
CRP level
(B) Quantile-Quantile plot of observed and expected P values for association with plasma
CRP level
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